IONIS PHARMACEUTICALS, INC.

Biopharma

Latest filing Jul 17, 2026

$760K

Reported income

Health Issues leads by disclosed activity

Filings

Most recent on Jul 17, 2026

Clients represented

IONIS PHARMACEUTICALS, INC. leads by reported income

Lobbyists employed

JORDAN CHAPMAN appears most prominently

Reported Income Over Time

Annual totals based on disclosed filing amounts.

2025

$320K3 filings

2026

$440K3 filings

Client Portfolio

The clients this firm represents, ranked by disclosed filing amounts.

IONIS PHARMACEUTICALS, INC.

Biopharma

6 filingsLatest Jul 17, 2026

Biotechnology company.

$760K

Lobbyists Employed

Lobbyists are ranked by appearances and an equal share of each filing's reported amount.

JORDAN CHAPMAN

What They Lobby On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Health Issues

HCR

6 mentions6 filingsLatest Jul 17, 2026

$253.3K

apportioned income

HOUSE OF REPRESENTATIVES6SENATE6

Medicare/Medicaid

MMM

Government Touchpoints

The entities named in disclosed activities are the clearest available signal for where the firm is directing attention.

01HOUSE OF REPRESENTATIVES

18 mentions

02SENATE

18 mentions

Industry Profile

AI-classified industry allocation based on the firm's filing activity.

Confidence

100%

Industry count

Biopharma

100%

Registrant industry was derived from a single labeled client relationship.

Recent Filings

The latest disclosures filed by this firm.

IONIS PHARMACEUTICALS, INC.Q2

2026 second quarter3 issues1 lobbyists

Medicare/MedicaidTaxation/Internal Revenue CodeHealth Issues

$150K

Jul 17, 2026

IONIS PHARMACEUTICALS, INC.Q1